HIV Clinical Info - Recommendations for the Use of Antiretroviral Drugs During Pregnancy and Interventions to Reduce Perinatal HIV

The Panel on Treatment of HIV in Pregnancy and Prevention of Perinatal Transmission (the Panel) has updated text and references throughout the guidelines to include new data and publications where relevant. These changes are highlighted in yellow in the PDF version of the guidelines. Some content has been reorganized among sections, with the creation of two new sections, changes to the sequence of some sections, and the addition of new tables to facilitate access to information. The Panel continues to move to the use of gender-neutral language but uses terms associated with female gender (e.g., mother, maternal) in some sections; this will continue to be reviewed in future updates.

Additional information to the following link: https://clinicalinfo.hiv.gov/en/guidelines/perinatal/whats-new